Genalyte
Genalyte, Inc. is a clinical and diagnostic life sciences company based in San Diego, California, that specializes in rapid diagnostic testing solutions for healthcare providers, patients, and researchers. Founded in 2007, Genalyte has developed a unique technology platform employing silicon photonic biosensors to quantify the interactions between biomolecules, such as antibodies and proteins. This innovative approach allows for the direct measurement of protein binding and nucleic acid hybridization, facilitating the monitoring of autoimmune diseases, cancer biomarker screening, and the detection of infectious agents, including Ebola. The company's Maverick platform enables rapid testing in various healthcare settings, with results typically available in under thirty minutes, thereby enhancing patient care and improving resource efficiency within the healthcare system.
BaseHealth
Acquisition in 2020
BaseHealth, Inc. offers a predictive health management platform that integrates genomic, medical, behavioral, and environmental data to assess disease risks and assist physicians in developing personalized action plans for patients. Founded in 2008 and headquartered in Redwood City, California, the platform utilizes machine learning to analyze vast amounts of medical literature and patient records, enabling healthcare providers to identify patients at risk for 43 chronic diseases. This proactive approach helps prevent expensive treatments by fostering collaboration between patients and physicians. Additionally, the platform provides tailored recommendations regarding nutrition and physical activity based on individual health conditions and genetic profiles. As of March 2020, BaseHealth operates as a subsidiary of Genalyte, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.